Hambrecht & Quist Capital Management »

R1 RCM shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of R1 RCM (RCM) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in R1 RCM

Tip: Access up to 7 years of quarterly data

All positions including R1 RCM held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in R1 RCM by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $6.6M 357k 18.45
2023-03-31 $5.4M 357k 15.00
2022-12-31 $2.2M 202k 10.95
2022-09-30 $3.8M 202k 18.53
2022-06-30 $4.2M 202k 20.96

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding R1 RCM

New Mountain Capital
Vanguard Group
Fil
BlackRock
Glazer Capital
Melqart Asset Management
State Street Corporation
Millennium Management
Coliseum Capital Management
Highland Capital Management Fund Advisors
Goldman Sachs Group
Empyrean Capital Partners
Dimensional Fund Advisors
Geode Capital Management
Paradigm Capital Management

View all funds holding R1 RCM